# CFI-400945 in Patients With Advanced/Metastatic Breast Cancer

> **NCT03624543** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Canadian Cancer Trials Group** · enrollment: 51 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** CFI-400945

## Key facts

- **NCT ID:** NCT03624543
- **Lead sponsor:** Canadian Cancer Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-02-14
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2026-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03624543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03624543, "CFI-400945 in Patients With Advanced/Metastatic Breast Cancer". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT03624543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*